Abstract

Carcinogenicity is a crucial endpoint for the safety assessment of chemicals and products. During the last few decades, the development of quantitative structure–activity relationship ((Q)SAR) models has gained importance for regulatory use, in combination with in vitro testing or expert-based reasoning. Several classification models can now predict both human and rat carcinogenicity, but there are few models to quantitatively assess carcinogenicity in humans. To our knowledge, slope factor (SF), a parameter describing carcinogenicity potential used especially for human risk assessment of contaminated sites, has never been modeled for both inhalation and oral exposures. In this study, we developed classification and regression models for inhalation and oral SFs using data from the Risk Assessment Information System (RAIS) and different machine learning approaches. The models performed well in classification, with accuracies for the external set of 0.76 and 0.74 for oral and inhalation exposure, respectively, and r2 values of 0.57 and 0.65 in the regression models for oral and inhalation SFs in external validation. These models might therefore support regulators in (de)prioritizing substances for regulatory action and in weighing evidence in the context of chemical safety assessments. Moreover, these models are implemented on the VEGA platform and are now freely downloadable online.

Highlights

  • Every day, people are exposed to numerous environmental chemical stressors that can have adverse health effects during their life

  • Data were collected from the Risk Assessment Information System (RAIS) Toxicity values database

  • If we look at the origin of the data, we see that the results for these three substances were extrapolated from inhalation tests on rats because they have a gaseous state at 20 ◦ C [45]

Read more

Summary

Introduction

People are exposed to numerous environmental chemical stressors that can have adverse health effects during their life. Exposure to toxic chemicals or mixtures comes from the environment, living places and workplaces, but diet, drugs and lifestyle are important concurrent sources as well [1,2,3,4]. Adverse effects include chronic diseases and cancer. Cancer is a major public health issue with more than 3 million new cases per year in the European Union [5,6]. The carcinogenic potential of a substance is evaluated by long-term in vivo carcinogenicity studies with laboratory animals. The conventional test for carcinogenicity is the two-year rodent carcinogenicity bioassay as described by the Organization for Economic Co-operation and Development (OECD) Test Guidelines 451 and 453 [7,8,9]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call